Collateral formation and clinical variables in obstructive coronary artery disease: The influence of hypercholesterolemia and diabetes mellitus

Coronary Artery Disease

Volumn 14, Issue 1, 2003, Pages 61-64

  Kornowski, Ran ^a,b  

^a TEL AVIV UNIVERSITY   (Israel)

^b RABIN MEDICAL CENTER   (Israel)

Author keywords

Angiogenesis; Atherosclerosis; Coronary artery disease

Indexed keywords

ADULT; AGE; AGED; ANGIOCARDIOGRAPHY; ANGIOGENESIS; ARTICLE; CLINICAL FEATURE; COLLATERAL CIRCULATION; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; CORRELATION ANALYSIS; DIABETES MELLITUS; FEMALE; HEART EJECTION FRACTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PREDICTION; PRIORITY JOURNAL; SCORING SYSTEM; SEX DIFFERENCE; SMOKING;

AGED; COLLATERAL CIRCULATION; CORONARY ANGIOGRAPHY; CORONARY ARTERIOSCLEROSIS; DIABETES MELLITUS; DIABETIC ANGIOPATHIES; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; LOGISTIC MODELS; MALE; MIDDLE AGED; NEOVASCULARIZATION, PHYSIOLOGIC;

EID: 0037295745     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019501-200302000-00007     Document Type: Article

References (18)

1. Epstein SE, Fuchs S, Zhou YF, Baffour R, Kornowski R. Therapeutic interventions for enhancing collateral development by administration of growth factors: basic principles, early results and potential hazards. Cardiovasc Res 2001; 49:532-542.
2. Freedman SB, Isner JM. Therapeutic angiogenesis for coronary artery disease. Ann Intern Med 2002; 136:54-57.
3. Rivard A, Fabre JE, Silver M, Chen D, Murohara T, Kearney M, et al. Age-dependent impairment of angiogenesis. Circulation 1999; 99:111-120.
4. Waltenberger J. Impaired collateral vessel development in diabetes: potential cellular mechanisms and therapeutic implications. Cardiovasc Res 2001; 49:554-560.
5. Van Belle E, Rivard A, Chen D, Silver M, Bunting S, Ferrara N, et al. Hypercholesterolemia attenuates angiogenesis but does not preclude augmentation by angiogenic cytokines. Circulation 1997; 96:2667-2374.
6. Abaci A, Oguzhan A, Kahraman S, Eryol NK, Ünal S, Arinç H, et al. Effect of diabetes mellitus on the formation of coronary collateral vessels. Circulation 1999; 99:2239-2242.
7. Schultz A, Lavie L, Hochberg I, Beyar R, Stone T, Skorecki K, et al. Interindividual heterogeneity in the hypoxic regulation of VEGF: significance for the development of the coronary artery collateral circulation. Circulation 1999; 100:547-552.
8. Rentrop KP, Cohen M, Blanke H, Phillips RA. Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects. J Am Coll Cardiol 1985; 5:587-592.
9. Stone GW, Peterson MA, Lansky AJ, Dangas G, Mehran R, Leon M. Impact of normalized myocardial perfusion after successful angioplasty in acute myocardial infarction. J Am Coll Cardiol 2002; 39:591-597.
10. Duan J, Murohara T, Ikeda H, Katoh A, Shintani S, Sasaki K, et al. Hypercholesterolemia inhibits angiogenesis in response to hindlimb ischemia: nitric oxide-dependent mechanism. Circulation 2000; 102(suppl 3):III370-III376.
11. Blann AD, Belgore FM, Constans J, Conri C, Lip GY. Plasma vascular endothelial growth factor and its receptor Flt-1 in patients with hyperlipidemia and atherosclerosis and the effects of fluvastatin or fenofibrate. Am J Cardiol 2001; 87:1160-1163.
12. Weis M, Heeschen C, Glassford AJ, Cooke JP. Statins have biphasic effects on angiogenesis. Circulation 2002; 105:739-745.
13. Levadot J, Murasawa S, Kureishi Y, Uchida S, Masuda H, Kawamoto A, et al. HMG-CoA reductase inhibitor mobilizes bone marrow-derived endothelial progenitor cells. J Clin Invest 2001; 108:399-405.
14. Cooper ME, Bonnet F, Oldfield M, Jandeleit-Dahm K. Mechanisms of diabetic vasculopathy: an overview. Am J Hypertens 2001; 14:475-486.
15. Rivard A, Silver M, Chen D, Kearney M, Magner M, Annex B, et al. Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF. Am J Pathol 1999; 154:355-363.
16. Chou E, Suzuma I, Way KJ, Opland D, Clermont AC, Naruse K, et al. Decreased cardiac expression of vascular endothelial growth factor and its receptors in insulin-resistant and diabetic states: a possible explanation for impaired collateral formation in cardiac tissue. Circulation 2002; 105:373-379.
17. Waltenberger J, Lange J, Kranz A. Vascular endothelial growth factor-A-induced chemotaxis of monocytes is attenuated in patients with diabetes mellitus: A potential predictor for the individual capacity to develop collaterals. Circulation 2000; 102:185-190.
18. Fuchs S, Shou M, Baffour R, Epstein SE, Kornowski R. Lack of correlation between angiographic grading of collateral and myocardial perfusion and function: implications for the assessment of angiogenic response. Coronary Artery Dis 2001; 12:173-178.